SCHEMBL19101813

SCHEMBL19101813

Nc1nc(F)nn2c([C@@H]3O[C@](N)(CI)[C@@H](O)[C@H]3F)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20960043 0.86 — —
SCHEMBL20756370 0.82 — —
SCHEMBL20960152 0.80 — —
SCHEMBL18379740 0.77 PNP (0.33) —
SCHEMBL16708590 0.77 PNP (0.33) —
SCHEMBL20943584 0.77 PNP (0.33) —
SCHEMBL16698792 0.76 POLRMT (0.41) —
SCHEMBL20756115 0.76 POLRMT (0.41) —
SCHEMBL807421 0.76 HIF1A (0.41) —
SCHEMBL18380007 0.76 HIF1A (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180016280-A1 PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES, INC. 2018-01-18 — — US disclosed
US-9701682-B2 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections GILEAD SCIENCES, INC. (US) 2017-07-11 — — US disclosed
Send feedback